FIELD: chemistry.
SUBSTANCE: in compound of formula I 
R1 is -(CH2)n-CO-NR5R6; -(CH2)n-COOR7; -(CH2)n- NR5R6; -(CH2)n-CN; -(CH2)n-OR8 or phenyl, which is unsubstituted or substituted with from one to three substituents, selected from halogen; R2 is hydrogen; R3 is hydrogen, (C1-C6)-alkyl, (C3-C6)-cycloalkyl or benzyl; R4 is halogen; R5 and R6 are hydrogen; R7 is hydrogen or C1-C6-alkyl; R8 is C1-C6-alkyl; m is 1, 2 or 3; and n is 0, 1 or 2.
EFFECT: increase of composition and treatment method efficiency.
5 cl, 2 dwg, 27 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2,3-DIHYDROISOINDOL-1-ONES POSSESSING INHIBITORY EFFECT ON MAO B ACTIVITY | 2003 |
|
RU2322437C2 |
| DERIVATIVES OF BENZIMIDAZOL INHIBITING FACTOR Xa | 2004 |
|
RU2346944C2 |
| PHTHALIMIDO-DERIVATIVES AS MONOAMINE OXIDASE B INHIBITORS | 2003 |
|
RU2317289C2 |
| TETRAHYDROTRIAZOLOPYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN NEUTROPHIL ELASTASE | 2012 |
|
RU2622643C2 |
| SPIRO-5,6-DIHYDRO-4H-2,3,5,10B-TETRA-AZA-BENZO[E]AZULENES | 2009 |
|
RU2514429C2 |
| PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
| MEK INHIBITORS AND THEIR THERAPEUTIC USE | 2021 |
|
RU2812929C1 |
| MACROCYCLIC PYRIDAZINONE DERIVATIVES | 2014 |
|
RU2660435C2 |
| PYRIDOPYRIMIDINE COMPOUND, METHOD FOR PRODUCTION, PHARMACEUTICAL COMPOSITION AND APPLICATION OF INDICATED COMPOUNDS | 2014 |
|
RU2662713C2 |
| DERIVATIVES OF 4-PYRROLIDINE PHENYL BENZOLE ETHER | 2003 |
|
RU2336268C2 |
